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Pseudonym	 Gender	 Age	 Occupation	 Ethnicity	
“Mira”	 Female	 40	 Registered	Nurse	 White	British	




“Jennifer”	 Female	 31	 Part-time	Sales	
Assistant	
White	British	
“Hannah”	 Female	 23	 Receptionist	 White	British	
“Emma”	 Female	 43	 Unemployed	 White	American	
“Izzie”	 Female	 32	 Teacher	 White	British	


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Pseudonym	 Gender	 Age	 Occupation	 Ethnicity	
“Mira”	 Female	 40	 Registered	Nurse	 White	British	
“Lynn”	 Female	 46	 Social	Worker	 White	British	






“Hannah”	 Female	 23	 Receptionist	 White	British	
“Emma”	 Female	 43	 Unemployed	 White	American	
“Izzie”	 Female	 32	 Teacher	 White	British	

































































































































































































































































































































































































































































































































































Psychology Research Ethics Committee 
School of Arts and Social Sciences 
City University London 







6th March 2017  
 
Dear Adriene Berkeley and Fran Smith 
 
Reference: PSYETH (P/L) 16/17 127 




I am writing to confirm that the research proposal detailed above has been granted approval by the City University 
London Psychology Department Research Ethics Committee.  
 
Period of approval 
Approval is valid for a period of three years from the date of this letter. If data collection runs beyond this period you 
will need to apply for an extension using the Amendments Form. 
 
Project amendments 
You will also need to submit an Amendments Form if you want to make any of the following changes to your 
research: 
 (a) Recruit a new category of participants 
 (b) Change, or add to, the research method employed 
 (c) Collect additional types of data 
 (d) Change the researchers involved in the project 
 
Adverse events 
You will need to submit an Adverse Events Form, copied to the Secretary of the Senate Research Ethics 
Committee  in the event of any of the following:  
 (a) Adverse events 
 (b) Breaches of confidentiality 
 (c) Safeguarding issues relating to children and vulnerable adults 
 (d) Incidents that affect the personal safety of a participant or researcher 
Issues (a) and (b) should be reported as soon as possible and no later than 5 days after the event. Issues (c) and 
(d) should be reported immediately. Where appropriate the researcher should also report adverse events to other 
relevant institutions such as the police or social services. 
 
Should you have any further queries then please do not hesitate to get in touch. 
 
Kind regards 
Hayley Glasford   Richard Cook 
Course Officer    Chair  






London - Camden & Kings Cross Research Ethics Committee 
Jarrow Business Centre 








21 April 2017 
 






Dear Miss Berkeley 
 
Study title: Minding the Bladder: Individuals Experiences of 
Adjustment to Chronic Pain Following Sacral 
Neuromodulation 
REC reference: 17/LO/0267 
Protocol number: N/A 
IRAS project ID: 217150 
 
Thank you for your letter of 12 April 2017, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by the Chair with the 
Alternate Vice-Chair. 
 
We plan to publish your research summary wording for the above study on the HRA website, 
together with your contact details. Publication will be no earlier than three months from the date 
of this opinion letter. Should you wish to provide a substitute contact point, require further 
information, or wish to make a request to postpone publication, please contact 
hra.studyregistration@nhs.net outlining the reasons for your request. 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 










Mrs Rosie Glazebrook Chair  
17/LO/0267 Please quote this number on all correspondence 
Appendix	E:	Online	Advertisement		
Department of Psychology 
City University London 
PARTICIPANTS NEEDED FOR 
RESEARCH IN: 
 
THE EXPERIENCE OF CHRONIC PAIN AFTER 
SACRAL NEURALMODULATION  
Are you aged between 20-55 and have had Sacral Neuromodulation? 
Have you experienced pain for at least 6 months? 
Would you like to inform how we think about supporting people living with the 
implanted device? 
We are looking for volunteers to take part in a study exploring adjustment to 
choric pain after successful Sacral Neuromodulation.  
You would be asked to take part in an interview lasting approximately 60-90 
minutes, focusing on your experience of chronic pain after surgery. 
 
For more information about this study, or to take part,  
please contact: 
Adriene Berkeley on  
Or Contact the Uro-Neurology department on  
‘Adjustment Study’ 
Research Supervisor: Dr Fran Smith
This study has been reviewed by, and received ethics clearance  
through the Psychology Research Ethics Committee, City University of London: PSYETH 
(P/L) 16/17 127   
If you would like to complain about any aspect of the study, please contact the Secretary to the University’s Senate Research Ethics Committee  










Minding the Bladder: Individuals Experiences of Adjustment to Chronic Pain Following Sacral 
Neuromodulation 
 
Ethics approval code: PSYETH (P/L) 16/17 127   
Please initial box 
1. I agree to take part in the above City University London research 
project. I have had the project explained to me, and I have read the 
participant information sheet, which I may keep for my records.  
 
I understand this will involve: 
• being interviewed by the researcher 
• allowing the interview to be videotaped/audiotaped 
 
2. This information will be held and processed for the following 
purpose: 
  
'What are the experiences of individual’s adjustment to chronic pain 
following successful sacral neuromodulation treatment?' 
 
I understand that any information I provide is confidential, and that 
no information that could lead to the identification of any individual 
will be disclosed in any reports on the project, or to any other party. 
No identifiable personal data will be published. The identifiable data 
will not be shared with any other organisation.  
 
 
3. I understand that my participation is voluntary, that I can choose not 
to participate in part or all of the project, and that I can withdraw at 
any stage of the project without being penalized or disadvantaged in 
any way. 
 
4. I agree to City, University of London recording and processing this 
information about me. I understand that this information will be used 
only for the purpose(s) set out in this statement and my consent is 
conditional on the University complying with its duties and 
obligations under the Data Protection Act 1998. 
 
5. I agree to have my GP contacted to advise him/her of my 
participation in this study. 
 





____________________ ____________________________ _____________ 
Name of Participant  Signature    Date 
 
 
____________________ ____________________________ _____________ 
Name of Researcher  Signature    Date 
 















Title of study: Minding the Bladder: Individuals Experiences of Adjustment to Chronic Pain Following 
Sacral Neuromodulation. 
 
We would like to invite you to take part in a research study. Before you decide whether you would like to 
take part it is important that you understand why the research is being done and what it would involve for 
you. Please take time to read the following information carefully and discuss it with others if you wish. Ask 
us if there is anything that is not clear or if you would like more information. 
 
What is the purpose of the study?  
Sacral Neuromodulation (SNM) is an effective treatment used to control irregular bladder symptoms. 
Often, individuals living with the implanted device experience pain for months after surgery. The purpose 
of this study is to explore those individual’s experiences of adjusting to chronic pain after successful 
control of bladder symptoms. It is hoped that that your views can contribute to the better understanding of 
individuals that undergo the SNM procedure and how they adjust to the consequences of bettering 
bladder function. This would expand knowledge of individuals experiences which could lead to future 
interventions targeting individuals experience.  
 
Why have I been invited? 
You have been invited because you have successfully undergone SNM as a pervious out-patient of the 
Uro-Neurology department at National Hospital for Neurology and Neurosurgery. 
 
Do I have to take part?  
No. Taking part in this study is voluntary, you to decide whether or not to take part. If you do decide to 
take part, you will be asked to sign a consent form. If you decide to take part, you are still free to withdraw 
at any time of the interview phase without giving a reason.  
 
What will happen if I take part? What do I have to do?  
If you are interested in taking part of this study, you will be invited to take part in in one interview session 
in the Uro-Neurology department at the National Hospital for Neurology and Neurosurgery. Interviews will 
involve discussing living with the implanted device, experiences of SNM and adjusting to chronic pain for 
approximately last between 60-90 minutes. Interviews will be audio recorded reordered, typed up and 
analysed by the researcher. You will only be asked to discuss you experiences related to SNM and 
adjusting to chronic pain. At any part of the process, you are free to withdraw at any time of the interview 
phase or decline any questions you are not comfortable answering. In addition, you will be invited to 
record diary entries over two weeks. The diary entry is not compulsory and are based on what you feel is 
relevant to include. In addition, if you would like to take part your GP/Health practitioner will be 
approached to advise them of your participation. Furthermore, if you decide to take part, data will be held 
for the length of the study only (1 year from consent) and will be destroyed appropriately. Personal 
information will also be irreversibly anonymised and disposed of directly after data collection (within 3 
months from consent).  
 
What will happen if I don’t want to carry on with the study?  
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You are free to withdraw the study, without reason, at any time before the period of analysis. You are able 
to request data withdrawal up to 14 calendar days after the interview. Data withdrawal after this point may 
not be possible after this window.  
 
 
What are the possible disadvantages and risks of taking part?  
Discussing your experiences may bring up various feelings due to the nature of the study’s sensitive 
topic. If this occurs during the interview process you are allowed to have a break during questioning, 
decline answering any uncomfortable questioning and can withdraw at any time of the interview phase. 
You will have access to the Clinical Nurse Specialist if you desire further support. If you would like discuss 
any aspect of the study you can contact the primary researcher Adriene Berkeley or the academic 
supervisor Dr Fran Smith. 
 
What are the possible benefits of taking part? 
The information gathered from the study will contribute to gaining greater understanding of individuals 
living with chronic pain after SNM and whether there are effective ways to support these individuals. 
Additionally, taking part of this study may be helpful as well as empowering as you will have the 
opportunity to self-reflect and explore your past experiences. 
 
What will happen when the research study stops?  
You will no longer have to share your experiences when the research study stops. Information given will 
be destroyed when the purpose of the study has been reached. 
 
Will my taking part in the study be kept confidential?  
Yes. Abiding by City, University of London ethics, NHS ethics and The Data Protection Act your 
participation in this study will be kept confidential. Only the researcher and academic supervisor will have 
sole access to the information collected. Participant data will anonymised, which includes the audio files 
of interviews not having any identifying information. Furthermore, complying with the regulations of the 
Data Protection Act, future use of information retained in this study will be prohibited. Confidentially will be 
maintained unless during the time of the interview phase you are at risk of harm to yourself or others or if 
the researcher becomes aware of issues of a criminal nature. At this point in time, information will be 
shared with supervisors and those necessary parties required. These events occur in only extreme 
circumstances and are thus unlikely. 
 
What will happen to the results of the research study? 
The results of the research study will be used for the researcher’s doctoral thesis for the degree of the 
Professional Doctorate in Counselling Psychology (DPsych). This thesis will be published. If you would 
like feedback at the end of this study, this can be provided to you in summary form through a letter after 
the analysis. 
 
What if there is a problem? 
If you have any problems, concerns or questions about this study, you should ask to speak to a member 
of the research team. If you remain unhappy and wish to complain formally, you can do this through the 
University complaints procedure. To complain about the study, you need to phone 020 7040 3040. You 
can then ask to speak to the Secretary to Senate Research Ethics Committee and inform them that the 
name of the project is: Minding the Bladder: Individuals Experiences of Adjustment to Chronic Pain 
Following Sacral Neuromodulation. 
 
You could also write to the Secretary at:  
Anna Ramberg 
Secretary to Senate Research Ethics Committee  
Research Office, E214 
City University London 
Northampton Square 
London 





In addition you can also contact UCLH PALS or  
 
Moreover, City University London holds insurance policies which apply to this study. If you feel you have 
been harmed or injured by taking part in this study you may be eligible to claim compensation. This does 
not affect your legal rights to seek compensation. If you are harmed due to someone’s negligence, then 
you may have grounds for legal action. 
 
 
Who has reviewed the study? 
This study has been approved by City University London Research Ethics Committee:  
Further information and contact details 
Adriene Berkeley -  or Dr Fran Smith -  
 
 







Appendix H: Letter to GP 
 
 
Study name: Minding the Bladder: Individuals Experiences of Adjustment to 
Chronic Pain Following Sacral Neuromodulation 
 
 
Dear Dr   ________________ 
 
Your patient:______________has expressed an interest in participating in a research study at the 
National Hospital for Neurology and Neurosurgery, Queen Square, UCLH. 
 
This is a qualitative study, which will explore the experiences of adjustment to chronic pain 
following sacral neuromodulation.  
 
Enclosed with this letter is a copy of the patient information sheet, which provides general 
information about the study aims, methods and procedures. 
 
For any queries regarding the study please contact the lead researcher, as detailed on the patient 
information sheet. 
 



















Amendment points discussed following meeting with London - Camden & Kings Cross 
Research Ethics Committee 
 
The Committee was satisfied with the responses to the following 
points raised in the previous letter.  
1. Confirmation that consent would not be taken over the 
telephone. 
2.  Confirmation that the debrief information sheet would not be 
utilised as it was unnecessary. 
3.  Amendment to the participant information sheet to detail what 
appropriate emotional or psychological support would be 
available if required. 
4.  Amendment to the consent form to obtain approval to contact a 
participant's GP.  
Amendments from the Committee following meeting:  
1. The Committee had concerns about calling people so they would 
be put in a position where they had to agree. The Committee 
would agree to this approach if it was made clear that the initial 
contact was by letter or email, and simply giving basic 
information about the study, and how to find out more, and 
leaving it for the potential participant to decide whether to act on 
this or not.  
2. The Committee agreed that the diary entry was still overly 
intrusive and suggested that participants should share much 
more information other that what was specifically needed. 
Members suggested a shorter, simpler entry to document points 
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research in clinical psychiatry and the basic sciences related to it. These include relevant 
fields of biological, psychological and social sciences. Review articles, editorials and 
letters to the Editor discussing published papers are also published. Contributions must be 
in English.  
Submission of manuscripts  
Manuscripts should be submitted online via our manuscript submission and tracking site, 
http://www.editorialmanager.com/psm/. Full instructions for electronic submission are 
available directly from this site. To facilitate rapid reviewing, communications for peer 
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Neuroscience-based Nomenclature  
For papers concerning neuropsychopharmacological treatments, Psychological Medicine 
encourages authors to utilize the ‘Neuroscience-based Nomenclature’ developed by the 
ECNP Taskforce on Nomenclature. The need for such a change arose to address a 
longstanding concern within the neuropsychopharmacological community that the 
nomenclature of psychotropic drugs did not properly reflect the underlying neuroscience 
of these compounds, as well as being unhelpful to clinicians and confusing to patients 
(e.g. the prescription of ‘antipsychotics’ for depression).  
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